ADA-friendly PDF: Genetic signatures expose drug susceptibility in breast cancer cells

Genetic Signatures Expose Drug Susceptibility in Breast Cancer Cells

Drug treatments for breast cancer patients might soon be designed based on the unique genetic autograph of their tumor. A genomics approach at the Medical University of South Carolina (MUSC) has unmasked genetic signatures in breast cancer cells that predict their sensitivity to certain drugs.

More at MUSC News